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Summary: The occurrence and characteristics of macromolecular components of normal human myometrium and
leiomyoma which bind [3H]estradiol and [3H]progesterone were investigated, employing dextran coated charcoal,
density gradient centrifugation and gel filtration techniques.
On sucrose density gradient centrigugation, [3H]progesterone was bound by macromolecules with sedimentation
rates of about 4 S and 8 S.
The major [3H]progesterone binding component had a sedimentation coefficient of about 4 S, which contained
specific and nonspecific binding sites.
Sedimentation patterns as well as elution profiles from agarose gel revealed a striking similarity between biochemical
properties of the progesterone receptors from normal myometrium and leiomyomas of the same organ.
Both progesterone and estradiql receptor change in concentration during the normal menstrual cycle. During the
early proliferative phase the number of estradiol receptor binding sites was highest; after ovulation, a rapid decrease
of estradiol receptor level was seen. On the other hand, using [3H]progesterone as the ligand, the highest receptor
concentration was found at midcycle.
The leiomyoma steroid hormone receptor levels were compared with those in normal myometrium. Whereas leiomy-
oma exhibited higher estradiol binding capacity, the concentration of progesterone receptors was low in fibroid
tumors.
Östrogen- und Progesterön-Rezeptören in normalem Human-Myometrium und Myomen
Zusammenfassung: Das Vorkommen makromolekularer Bindungskomponenten für [3H]Östradiol und [3H]Pro-
gesteron in normalem Human-Myometrium und Myomen wurde untersucht und die Charakterisierung mit Hilfe der
Dichtegradienten-Zentrifugationstechnik und Gelfiltration vorgenommen. Die Quantifizierung erfolgte mit einer
modifizierten JDextran-Aktivkohle-Technik.
Im Saccharöse-Dichtegradienten sedimentierte im KCl-freien Medium der [3H]Progesteron-Rezeptor im 4 S- und
8 S-Bereich. Die Häüptbindungskomponente war im 4 S-Bereich lokalisiert, die neben spezifischen Bindungsbezirken
unspezifische Bindungsaktivität aufwies.
Die Sedimentationsprofde sowie die Elutiönsprofile «nach Agarose-Gelfiltration demonstrieren eine auffällige Ähn-
lichkeit zwischen den biochemischen Eigenschaften der Progesteron-Rezeptoren aus normalem Myometrium und
Myomen des gleichen Uterus.
In normalem Gewebe variieren die Prqgesterqn- sowie Östradiol-Rezeptorkonzentrationen in der Cytoplasmafraktion.
Die höchsten Östradiol-Rezeptorbindungsaktivitäten wurden während der frühen Proliferationsphase beobachtet;
nach Oviüation kommt es zu einem rapiden Abfall der Östradipl-Rezeptorkohzentration. Die höchsten Progesteron-
Rezeptorkonzentratipnen zeichneten sich ab in der Mitte des Menstruationszyklus zum Zeitpunkt der Ovulation.
Myome waren charakterisiert durch hohe Östradiql-Bindungskäpazität und eine niedrigere Progesteron-Rezeptorkon-
zentration.
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Introduction
The uterus, the target organ for ovarial steroid hor-
mones, has a property characteristic of target organs,
i. e., the accumulation of steroid hormones against a
concentration gradient. Specific high affinity cytoplasmic
receptor proteins for steroid hormones, whose existence
was first demonstrated by Jensen et al. (1), are respon-
sible for this phenomenon. These receptor proteins, of
which there is one specific type for each steroid hormone,
are essential components in the chain of action of
steroid hormones in the target cell. After the steroid
hormone has entered the target cell from the blood, it
binds to the appropriate receptor molecule to form a
hormone-receptor complex, which translocates to the
nucleus after activation. In the nucleus, the site of the
genetic apparatus, the hormone receptor complex binds
to the chromatin. This interaction leads to activation at
the transcription level, followed by an increase in
protein synthesis. Although a large number of the
individual processes in this sequence are still unclear, it
is probable that some of them are the cause of growth
and/or differentiation of the uterus under the influence
of steroid hormones.
Studies on the specific cytoplasmic receptor proteins
binding estradiol and progesterone in human myometrium
and endometrium have shown that the concentrations
of these steroid hormone receptors change during the
course of the menstrual cycle (2—10). Practical clinical
experience has also shown that the growth of leiomy-
omas, benign neoplasias of the muscle layer of the
uterus, can be affected by changes in the hormone
status during the menstrual cycle and during pregnancy.
The question is, why leiomyomas escape the growth
inhibition exerted by the surrounding hormonal
milieu, and develop, so to speak, their own growth
control. Comparison of the steroid hormone receptors
in normal myometrium and leiomyomas from the same
uterus may help to answer this question. In this connec-
tion, not only the quantitative analysis of the estrogen
and progesterone binding receptor molecules is of
interest, but also the biochemical characterization of
the two receptors in normal and neoplastic tissues.
Materials and Methods
Steroids
(1, 2-3H)Progesterone (spec, activity 1.96 PBq/mol =
53 Ci/mmol) and [6, 7-3H]estradiol-170 (spec, activity
1.48 PBq/mol = 40 Ci/mmol) were purchased from the'Radio^
chemical Centre (Amersham, England). All radioactive steroids
were purified by thin-layer chromatography before use.
Unlabelled steroids were a gift from Schering AG (Berlin, Ger-
many).
Tissue
Uterine tissue was obtained from normal fertile or postmeno-
pausal women, who underwent hysterectomy because of
myomata uteri. Immediately after hysterectomy the uterus
was placed on ice, myometrium and endometrium were
separated from one another, and portions of each tissue were
removed for microscopic study. The interval between hys-
terectomy and the start of the cytosol preparation was usually
less than 30 min. The menstrual age of the rnypmetrium was
based on a 28-day cycle by rating histological sections of
normal endometrium according to the scheme ofNoyes et al.
(11).
Preparat ion of subcellular fract ions
Tissue was processed at 4 °C. Fresh tissue samples were weighed,
washed in ice cold buffer (containing 50 mmol/1 tris/HCl,
pH 7.0,1.25 mmol/1 EDTA, 12 mmol/1 mercaptoethanöl,
200 ml/1 glycerol), and gently homogenized in a 4rfold volume
(w/v) of the same buffer. Homogenization was performed with
an Ultra Turrax for 5 pulses (each 20 s). This homogenization
was followed by homogenization with a glass homogenizer
fitted with a teflon pestle (5 strokes). The homogeriate was
filtered through 4 layers of cheese-cloth. To obtain the nuclear
fraction, the filtrate was centrifuged at 850 # for, 15 min, and
the nuclear pellet washed twice in buffer A (10 mmol/1 tris/
HC1, 0.1 mol/1 NaCl, 5 mmol/1 KC1, 3 mmol/1 MgCl2, 1.5 mmol/1
CaCl2> 200 ml/1 glycerol, 7.0) by dispersing with a Dounce
homogenizer and centrifuged twice at 85 0# for 15 min. The
nuclear pellet was resuspended in buffer A containing 2.4 mol/1
sucrose, layered on a cushion of 2.4 mol/1 sucrose buffer A and
centrifuged at 60,000 £ for 60 mm at 4 °C. The resulting pellet
was designated the "purified nuclei".
The 850 £ supernatant was centrifuged for 30 min at 105,000£
to obtain a clear cytosol containing only the fully soluble pro-
teins.
Serum was obtained by low speed centrifugation of the blood
samples of pregnant women and was stored at - 70 °C.
Sucrose densi ty gradient cen t r i fuga t ion
Samples (4.6 mg protein per ml cytosol) for density gradient
centrifugation (5 to 20% linear sucrose gradient in tris-EDTA-
mercaptpethanpl-glycerol buffer) with or without KC1 were
reacted for 10 h at 4 °C with 2 nmol/1 [3H]progesterone without
any competitor. In a second set of tubes a 100-fold excess of
unlabelled progesterone or cortisol was added to the radioactive
steroid. Incubations were performed for 16 h at 4 °C. There-
after 0.2 ml aliquots of the samples were centrifuged for 16 h
at 234,000£ (rotor SW 50.1, Beckman Instruments).
Bovine serum albumin was run simultaneously as the reference
protein in the estimation of sedimentation coefficients. Frac-
tions were collected from the top of the gradient by means of
the Isco-piercing unit and drop counter. Radioactivity was
determined in 0.1 ml aliquots of undiluted fractions. Quenching
of radioactivity by sucrose did not vary significantly. .
Agarose gel f i l t ra t ion
Bio Gel A-0.5 m (200-400 mesh, Bio-Rad Laboratories, Mün- ·
chen, Germany) was packed in columns (1.5 cm i. d.) to a
height of 100 cm and washed with the elating buffer solution
(tris-EDTA-mercaptoethanol-glycerol buffer). The gel exclusion
characteristics of the column were measured with standard
proteins. Samples (15.8 mg protein per nil eytosol) were applied
to the column in 2 ml volumes together with Chlorophenol
Red and Dextran Blue to serve as indicators. Dextran Blue was
eiuted in the void volume while the red dye was eluted with
free [3H]steroid. Elution was carried out at a flow rate of
8.5 ml/h. Then 1.5 ml fractions were collected and aliquots
were counted for radioactivity.
M e a su re m en t of p roges te rone b ind ing sites
in m y o m e t r i a l cy tosol by equi l ibr ium dialysis
Cytosols were diluted with tris-EDTA-mercaptoethanotglycerol
buffer to a final protein concentration of 1 g/1. The equilibrium
dialysis was performed according to the method described in
detail by Davies (12). A dialysis bag containing 1 ml of cytosol
was introduced into 5 ml of homogenization buffer containing
increasing concentrations of [3H]progesterone (0.2-20 nmol/1)
and a constant amount of unlabelled cortisol, 100-fold molar
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excess over the highest [3H]steroid level. Cortisol was added
to eliminate binding by contaminating serum corticosteroid-
binding globulin. The diluted cytosols were incubated at 4 °C
for 16 h with shaking. The deviation of the number of binding
sites as well as the association constant (Ka) from the multiple
dialysis were based on linearization of the data as described
by Scatchard (13).
De t e rmina t i on of es t radiol b i n d i n g
The diluted cytosols (1 g/1) were incubated at 4 °C for 16 h
with [3Hjestradiol over a 30-fold concentration range (0.5 to
15 nmol/1). Tubes containing 1 μηιοΐ/l unlabelled estradiol
were used to correct for nonspecific binding. Binding was then
measured using the charcoal adsorption technique: The pellet
obtained from the centrifugation (2 min at 10,000 g) of 0.4 ml
of 2.5 g/1 charcoal plus 0.25 g/1 dextran in 50 mmol/1 tris/HCl
buffer (pH 7.0) was mixed with the cytosol; after 20 min at
4 °C, the dextran-coated charcoal was removed by centrif ugation
for 10 min at 10,000 £. The bound radioactivity of the samples
was counted for radioactivity.
The association constant (Ka) and the concentration of binding
sites were calculated according to Scatchard.
Assay of nuc lea r b i n d i n g
of [ 3 H jes t rad io l and [3 H ]proges terone
Myometrial tissue slices were incubated in Eagle's medium at
37 °C for 60 min with 5 nmol/1 [3H]progesterone or [3H]estra-
diol. Purified nuclear fractions were prepared as described
above and extracted with 0.4 mol/1 KC1,10 mmol/1 tris/HCl
(pH 7.0), 1.5 mmol/1 EDTA buffer, at 4 °C for 30 min.
Aliquots of 0.4 mol/1 Kd extracts (0.2 ml) were layered onto
50-200 g/1 sucrose gradients, containing 0.3 mol/1 KC1 as
described above.
In order to determine the transfer of [3H]estradiol or [3H]pro-
gesterone from cytosol to nucleus, tissue slices from early
proliferative and early secretory myometrium as well as
leiomyoma were incubated in &agle*s medium for 10 min at
4 °C, then rinsed and transferred to fresh Eagle*s medium and
incubated for various periods as indicated at 37 °C. After
incubation the tissue was homogenized and fractionated as
described under "Preparation of subcellular fractions'*. The
nuclear pellet was purified by passing through 2.4 mol/1
sucrose. The cytoplasmic fraction and purified nuclei were
then extracted with chloroform/ethanpl (3 ml + 1 ml). The
ordinate is expressed as counts per min per 1.0 g of tissue.
Protein assay
Protein was measured using the method ofLowry et al. (14)
with bovine serum albumin as standard.
Results
The kinetics of [3H]progesterone binding to specific
receptor molecules of human 'normal myometrium and
leiomyoma cytosol is demonstrated in figure 1. It is
evident that after 10 h at 4 °C, the amount of bound
radioactivity remained constant up to 100 h of incuba-
tion. In all further experiments an incubation time of
at least 16 h was employed.
Figure 2 illustrates the rates of dissociation of [^pro-
gesterone from the cytosol receptor binding site from
myometrium and leiomyoma. The two progesterone
receptor complexes have similar dissociation rates.
Sucrose density gradient (50 to 200 g/1) centrifugation
of normal myometrium and leiomyoma cytosol incu-















Fig. 1. Kinetics of [ HJprogesterone binding to cytosol com-
ponents in human myometrium in the early secretory















Fig. 2. Dissociation rate of cytoplasmic progesterone receptor
complexes of early secretory myometrium (closed circles)
and leiomyoma (closed squares).
Cytosol was incubated with 2 nmol/1 radioactive iigand
for 16 h at 4°C. Unlabelled progesterone (100 nmol/1)
was added and bound radioactivity was measured at
different times by the dextran coated charcoal technique.
0.3 mol/1 KC1 produced a marked radioactivity peak in
the 4 S region (fig. 3).
Ur belled cortisol partially displaced [3H]progesterone
from this binding component, while unlabelled pro-
gesterone was capable of almost complete displacement
of [3H]progesterone from the 4 S binding component.
In the absence of KC1, two peaks of radioactivity with
sedimentation rates of about 8 S and 4 S were noted
on density gradient centrifugation. The sedimentation
profiles revealed a striking similarity between receptors
of normal myometrium and leiomyoma, but the amounts
of [3H]progesterone in the 4 S and 8 S regions were
reduced in leiomyoma samples. As presented in this
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Fig. 3. Sedimentation properties of progesterone binding proteins at different KCL-concentrations in human myometrium, leiomyo-
ma, and pregnant serum.
The samples were incubated with 2 nmol/1 [ HJprogesterone alone or in the presence of a lOO^fold excess of unlabelled
steroids.
figure the 4 S component is not distinguishable from
the corticosteroid binding globulin (CBG) of human
pregnant serum.
The elution patterns shown in figure 4 were obtained
when progesterone-labelled cytosols of normal miypme-
trium and leiomyoma were chromatographed on
agarose gel in the presence of 0.3 mol/1 KCl. The major
progesterone binding activity chromatographed as a
single peak (fraction number 60) close behind CBG;
free [3H]progesterone was eluted within the elution
volume of fraction 80 to 100. The radioactive peak of
fraction 60 was mostly eliminated by the addition of
unlabelled progesterone during the incubation of eytosol
with [3H]progesterone. The elution profiles obtained
with normal human myometrium were similar to those
of leiomyoma, except that binding of [3H]progesterone
was very low in the main peak of radioactivity (fraction
number 60).
Concentration of the
cytoplasmic progesterone binding components
during the menstrual cycle and in leiomyoma
Trie progesterone receptor levels found at various times
in the menstrual cycle are shown in figure 5. Dating of
the myometrial tissue was performed by staging
endometrial samples of the uterus histologically with
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Fig. 4. Chromatographie patterns obtained from agarose gel
filtration of cytoplasmic [3H]progesterone binding com-
ponents of normal myomethum and leiomyoma ob-
tained from the same tumor-bearing uterus.
Cytosol samples were incubated with 2 nmol/1 [3H]pro-
gesterone for 10 h at 4°C with or without 100-fold
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Fig. 5. Concentration of specific progesterone binding sites of
normal human myometrial cytosol in relation to the day
of the menstrual cycle.
For the determination of the progesterone receptor con-
centration, myometrial cytosol was incubated with in*
creasing amounts of [3H progesterone in the presence
of an excess of unlabelled cortisol.
respect to the phase of the menstrual cycle. In general,
the proliferative specimens contain significantly higher
concentrations of progesterone receptor than the
secretory samples. During the proliferative phase the
progesterone receptor level increased toward the 14th
day of the menstrual cycle, reached its highest value
around the time of ovulation and declined sharply
during the secretory phase.
In figure 6 the specific progesterone binding capacity
of cytosol obtained from normal myometrium is
plotted against the age of the women. The highest
binding site concentrations were found in tissue samples
of normal fertile women; in postmenopausal uteri the
specific binding capacity was low.
The cytosols of 16 leiomyomas were examined for the
presence of progesterone-specific binding (fig. 7). In
all tumor samples progesterone binding activity was
detectable, but the leiomyomas had significantly lower
binding activity than did normal human myometrium
obtained from normal fertile or postmenopausal women.
A comparison of the Kd-values of the progesterone
receptor complex in each stage of the menstrual cycle,
in postmenopausal tissue or in leiomyoma indicated
that there was no statistically significant difference in
their dissociation constants (normal myometrium:
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Fig. 6. Progesterone receptor concentration in human myomet-
rial cytosol in relation to menopausal status.
• = proliferative myometrium; χ = secretory myometrium






































Fig. 7. Comparison of the binding capacity of cytosol of normal
myometrium and leiomyoma for progesterone in pre- and
postmenopausal women (prol. = proliferative phase;
secret. = secretory phase; atroph. = atrophic endometrium).
Numbers in bars represent the number of patients studied.
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Concentration
of the specific estradiol binding sites
during the menstrual cycle and in leiomyoma
The level of unoccupied specific cytoplasmic estradiol
receptor reached a maximum early in the first half of
the cycle and steadily declined thereafter, to its lowest
value late in the secretory phase (fig. 8).
The influence of the age of the patient on the cyto-
plasmic estradiol receptor content in normal myome-
trium is shown in figure 9. Premenopausal .patients were
those regularly menstruating; postmenopausal ones
had their last menstrual period at least 1 year before.
With regard to the mean receptor concentrations, the
estradiol receptor levels were significantly lower in
pre- than in post-menopausal women, whereas the
reverse was true for the progesterone receptor binding
activity (see fig. 6). The cytosols of 32 leiomyomas













Fig. 10. Comparison of the binding capacity of cytosol of nor-
mal myometrium and leiomyoma for estradiol in pre-
and post-meriopausal women,
prol. = proliferative phase; secret. = secretory phase;
atroph. = atrophic endometrium
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Fig. 8. Specific [3H]estradiol binding concentration of myomet-
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Fig. 9. Estradiol receptor concentration in human myometrial
cytosol in relation to menop usal status.
• = proliferative myometrium; τ = secretory .myomet-
rium; χ = postmenopausal myometrium (atrophic endo^
metrium).
binding (fig. 10). The concentration of estradiol
receptors was riot significantly different in leiomyomas
and normal myometrium. There was no evident correla-
tion between the association constant and the histological
type of the tissue (normal myometrium: 6.8 + 0.3 ·
109 1/mol; leiomyoma: 8.8 + 0.2 · 109 1/mol).
Nuclear estradiol and progesterone receptors
The variation of binding profiles as a function of the
menstrual cycle is shown in relation to nuclear [3H]estra-
diol- and [3H]progesterone-binding profiles in leiomyoma
(fig. 11). Under high resolution conditions, no significant
difference in the sedimentation patterns of nuclear
[3H]estradiol and [3H]progesterone binding sites from
proliferative myometrium and leiomyoma could be
found. These patterns were characterized by high
[3H]estradiol and low [3H]progestefone binding
activity. In the nuclear myometrial extract of the
secretory phase, the converse was the case.
Myometrial tissue slices were pre-incubated for 10 min
at 4 °C to allow passive diffusion of the [3H]labelled
steroids into the cell, and the tissue was then incubated
for various periods of time as indicated in figure 11.
The relative [3H]coiitents of the cytoplasm arid purified
nuclei were then determined. Initially, for both
[3H]estradiol and [3H]progesterone, the tritium was
located almost completely in the cytosol fraction,
while relatively little was present in the purified nuclear
pellet. Upon continued incubation, there was an in-
crease in nuclear [3H]binding and progressive decrease
in{3HJbinding in cytoplasmic binding components,
suggesting that the hormone was sequentially transferred
to the nucleus. The transfer mechanism in leiomyoma
is comparable to tfiat in the normal proliferative phase
myometrium.
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Fig. 11. [3H]estradiol (closed line) and [3H]progesterone (dotted line) binding components of myometrial nuclei demonstrated by
sucrose density gradient centrifugation.
Nuclei were prepared from early proliferative and early secretory phase of normal human myometrium and from leiomyoma
















Fig. 12. Transfer of [3H]estradiol and [3H]progesterone from
cytosol to nucleus.
Tissue slices from early proliferative (3 cases) and early
secretory (5 cases) myometrium and from leiomyoma
(4 cases) were incubated in Eagle's medium for 10 min at
4° C, then rinsed and transferred to fresh Eagle's medium
and incubated for various periods as indicated. After in-
cubation the tissue was homogenized and fractionated
as described under "Materials and Methods". Cytoplasmic
fraction (-—) and purified nuclei (^ ^= -) were then ex-
tracted with chloroform/ethanol (volumes, 3 + 1).
Discussion
The results of the present studies demonstrate the
existence of high-affinity, low-capacity binding compo-
nents for estradiol and progesterone in the cytoplasmic
fractions of normal myometrium and leiomyomas.
These specific hormone-binding protein components
have the properties of receptors (sedimentation in
density gradients, competitive binding studies, elution
profile after agarose gel filtration, high affinity binding).
These observations confirm the studies of others
(15-27).
Comparison of the biochemical properties of the cyto-
plasmic progesterone binding receptor molecules from
normal and neoplastic myometrium (for the estradiol
receptor, see Follow et al., 1. c. (28)) shows that there
are no differences between the receptors from these
two tissues with respect to their affinity for progesterone,
their sedimentation properties in sucrose density
gradient, or their elution profile after agarose gel filtra-
tion. This indicates that the neoplastic tissue contains
a progesterone receptor which is similar or identical to
the one found in normal human myometrium. Quanti-
tative differences between the two types of tissue were
observed with respect to binding of ovarial steroid
hormones. In normal human myometrium, the concentra-
tion of progesterone binding receptor sites varies during
the menstrual cycle. Cycle-dependent variations in the
concentration of the receptor proteins are particularly
interesting, because the hormone receptors directly
influence the control of the genetic apparatus. The
highest concentrations of progesterone receptors were
observed in mid-cycle. This is an agreement with the
results oflllingworth et al. (26), and Kontula (21).
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Examination of the estradiol receptors in the myome-
trium during the fertility period showed that the highest
cytoplasmic concentrations occur during the prolifer-
ative phase. There may be two causes for the changes in
steroid hormone receptor concentration in the myo-
metrium during the menstrual cycle:
1. Progesterone, the predominant steroid hormone
during the second half of the cycle, acts as a negative
effector both for its own receptor and for the estradiol
receptor, reducing the concentration of both during
the second half of the cycle, and
2. due to the inductive effect of the progesterone
receptor mechanism, there is a large increase in 17/J-
hydroxysteroid dehydrogenase activity, which reduces
the intracellular estradiol concentration.
The result is that the estradiol receptor mechanism,
which is responsible for both its own induction and that
of the progesterone receptor, is blocked (10, 29, 30).
The results of the comparative analysis of steroid hor-
mone receptor levels in normal myometrium and leiomy-
omas from the same uteri are rather interesting. The
present study shows that leiomyomas are characterized
by low cytoplasmic concentrations of progesterone
receptors, but high estradiol receptor levels, comparable
to those in normal myometrium. This observation is
supported by the comparison of the sedimentation
patterns of nucleus-bound steroid hormone receptors
from normal myometrium in the middle proliferative
and early secretory phases and from leiomyoma, and
by kinetics of steroid hormone transfer from the cyto-
plasm to the nucleus under equilibrium conditions.
Our results on the estradiol receptor are in agreement
with the findings of Farber et al. (31),Puukka et al.
(33) and with the most recent data of Daxenbichler
et al. (32), who were also unable to find any significant
differences in the estradiol receptor complement of
leiomyoma and normal myometrium. However, there
is a discrepancy with respect to the progesterone
receptor content: Daxenbichler et al. found no signifi-
cant differences between the two types of tissue,
although they report a tendency toward lower pro-
gesterone receptor concentrations in the leiomyomas
of patients older than 45 years than iri normal myo-
metrium from patients of the same age. It is possible
that there is a methodological reason for the differences
in quantitative results on the progesterone receptors:
Daxenbichler et al. used a dextran-coated charcoal
procedure with [3H]R 5020 as gestagen. This is a
high potency, high-affinity synthetic gestagen with a
low dissociation constant, while in the present work,
the natural [3H]progesterone was used with a multiple
dialysis technique.
The low progesterone receptor concentrations found
here are supported by the observation of Follow et al.
(34) that leiomyomas are characterized by low 17/3-
hydroxysteroid dehydrogenase activity, and this enzyme,
as studies by Tseng & Gurpide (29, 30) and our group
(10) on human endometrium have shown, is subject
to the inductive effect of the progesterone receptor
mechanism. One can only speculate on the cause and
pathophysiological significance of the differences in
progesterone receptor contents of normal myometrium
and leiomyoma: Since, as animal experiments have
shown, the progesterone receptor is induced via the
estradiol receptor mechanism, and thus represents an
end product of the chain of estradiol action, it can
be inferred that an alteration at one of the steps sur>
sequent to the translpeation of the estradiol receptor
(transcription, processing, translation) leads to the
"progesterone receptor defect". Since the progesterone
receptor mediates the physiological braking action of
progesterone on the biologically active estradipl, which
is responsible for proliferation and mitosis activity, the
possibility cannot be excluded that the continuous and
uninhibited estrogen stimulation is a cofactor supporting
the neoplastic transition. It is too early to speak of an
etiological factor, however^ since correlations do not
prove etiology.
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